PRESS RELEASE published on 01/21/2025 at 17:45, 1 year 8 months ago Alstom S.A. : Troisième trimestre de l’exercice fiscal 2024/25 d’Alstom : perspectives pour l’exercice fiscal 2024/25 confirmées Alstom confirme ses perspectives pour l'exercice fiscal 2024/25 avec des commandes en hausse et une croissance organique du chiffre d'affaires Croissance Organique Perspectives Commandes Alstom Exercice Fiscal
PRESS RELEASE published on 01/21/2025 at 17:45, 1 year 8 months ago Alstom S.A.: Alstom’s third quarter 2024/25: confirmed outlook for FY 2024/25 Alstom's Q3 2024/25: Order intake reaches €4.3B, sales at €4.7B, organic growth 6.9%. FY 2024/25 outlook strong with book-to-bill above 1 and sales growth 5% Sales Growth Order Intake Alstom Q3 2024/25 FY 2024/25 Outlook
PRESS RELEASE published on 01/21/2025 at 17:45, 1 year 8 months ago Acquisition ou cession des actions de l'émetteur / Information relative au contrat de liquidité Bilan semestriel S2 2024 du contrat de liquidité avec la société de bourse Gilbert Dupont. Détails des transactions d'achat et de vente au cours du 2nd semestre 2024 Contrat De Liquidité Bilan Semestriel Transactions D'achat Transactions De Vente Société De Bourse
PRESS RELEASE published on 01/21/2025 at 17:45, 1 year 8 months ago Transgene participera à la conférence investisseurs Biomed Forum Transgene participera à la conférence investisseurs Biomed Forum le 4 février 2025. Présentation de ses immunothérapies contre le cancer reposant sur des vecteurs viraux BIOMED Forum Immunothérapie Cancer Transgene Vecteurs Viraux
PRESS RELEASE published on 01/21/2025 at 17:45, 1 year 8 months ago Transgene to Participate in the Biomed Forum Investor Conference Transgene's management team to participate in the Biomed Forum Investor Conference in Paris on February 4, 2025 Investor Conference Paris BIOMED Forum Transgene February 4
PRESS RELEASE published on 01/21/2025 at 17:45, 1 year 8 months ago Acquisition or disposal of the issuer's own shares / Information relating to the liquidity contract Mauna Kea Technologies' liquidity contract statement for H2 2024 with Gilbert Dupont shows buy and sell side transactions. Company specializes in real-time cellular imaging technology Liquidity Contract Gilbert Dupont Mauna Kea Technologies H2 2024 Cellular Imaging
PRESS RELEASE published on 01/21/2025 at 17:42, 1 year 8 months ago A Comprehensive Guide to iMe: Features, LIME Functions, and 2025 Roadmap iMe, a Telegram-based platform blending messaging with crypto, AI, and NFTs, showcases growth and innovations in 2024, setting ambitious goals for 2025 AI NFTs Crypto IMe Telegram-based Platform
PRESS RELEASE published on 01/21/2025 at 17:40, 1 year 8 months ago VALBIOTIS SA: Valbiotis unveils its strategic and financial goals for 2030 Valbiotis unveils its strategic and financial goals for 2030, focusing on product releases, turnover targets, and international sales expansion. Detailed roadmap and value proposition presented Valbiotis Strategic Goals International Sales Financial Goals Product Releases
PRESS RELEASE published on 01/21/2025 at 17:40, 1 year 8 months ago VALBIOTIS SA: Valbiotis dévoile ses ambitions stratégiques et financières à horizon 2030 Valbiotis dévoile ses ambitions stratégiques et financières à horizon 2030 avec trois produits pour la prise en charge des troubles cardio-métaboliques sur le marché en France dès 2025 Commercialisation Valbiotis Ambitions Stratégiques Financières Cardio-métaboliques
PRESS RELEASE published on 01/21/2025 at 17:40, 1 year 8 months ago Affluent Medical : Bilan semestriel du contrat de liquidité. Bilan semestriel du contrat de liquidité d'Affluent Medical avec Rothschild Martin Maurel. Détails des transactions et volumes échangés au 31/12/2024 Contrat De Liquidité Rothschild Martin Maurel Bilan Semestriel Transactions Affluent Medical
Published on 10/03/2026 at 02:35, 2 days 2 hours ago Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 13:50, 2 days 15 hours ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 2 days 16 hours ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 2 days 16 hours ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/05/2026 at 00:05, 5 hours 14 minutes ago TerraMaster lance sa saison de mise à niveau du stockage avec jusqu’à 30 % de réduction à l’occasion des Prime Big Deal Days
Published on 10/04/2026 at 06:05, 23 hours 13 minutes ago Blokees Debuts 90+ New Products at Wonder Festival Shanghai 2026
Published on 10/04/2026 at 05:15, 1 day ago SIBIONICS and PharmaSens Explore New Horizons for Automated Insulin Delivery at EASD 2026
Published on 10/03/2026 at 15:45, 1 day 13 hours ago Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 2 days 5 hours ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 17:45, 2 days 11 hours ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 2 days 11 hours ago Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 2 days 11 hours ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 2 days 11 hours ago Aéroports de Paris SA - 2027 Financial Calendar
Published on 10/02/2026 at 17:30, 2 days 11 hours ago Aéroports de Paris SA - Calendrier financier 2027
